NanoCarrier 4571

ナノキャリア

NanoCarrier Co., Ltd.

Recent Updates

2021-12-27

Patient enrollment completed in Japan for the Phase III study of VB-111 targeting ovarian cancer

2021-12-20

Patient registration target reached for Phase IIb study of NC-6004 and Keytruda combination therapy

2021-12-03

Over 70% patient registration completed in Japan for Phase III study of VB-111 for ovarian cancer

Get in touch

1-4-10 Kyobashi, Chuo-ku, Tokyo, 104-0031

https://www.nanocarrier.co.jp/

Summary

NanoCarrier is a pharmaceutical venture company undertaking the development of nanomedicine based on micellar nanoparticle technology.

Biotechnology

Key dates

2009-09-07

Coverage initiation

1H FY 03/22 flash update

You can read the report update by signing up for a free account

Already have an account? Sign in